CHC Healthcare Group
CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitatio… Read more
CHC Healthcare Group - Asset Resilience Ratio
CHC Healthcare Group (4164) has an Asset Resilience Ratio of 0.46% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how CHC Healthcare Group's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down CHC Healthcare Group's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$67.75 Million | 0.46% |
| Total Liquid Assets | NT$67.75 Million | 0.46% |
Asset Resilience Insights
- Limited Liquidity: CHC Healthcare Group maintains only 0.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CHC Healthcare Group Industry Peers by Asset Resilience Ratio
Compare CHC Healthcare Group's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
China Meheco Co Ltd
SHG:600056 |
Medical Distribution | 0.35% |
Annual Asset Resilience Ratio for CHC Healthcare Group (2009–2024)
The table below shows the annual Asset Resilience Ratio data for CHC Healthcare Group.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.59% | NT$83.38 Million | NT$14.21 Billion | -0.41pp |
| 2023-12-31 | 1.00% | NT$135.47 Million | NT$13.61 Billion | -0.93pp |
| 2022-12-31 | 1.93% | NT$247.06 Million | NT$12.83 Billion | -1.46pp |
| 2021-12-31 | 3.38% | NT$425.30 Million | NT$12.57 Billion | -0.02pp |
| 2020-12-31 | 3.41% | NT$393.54 Million | NT$11.54 Billion | +0.11pp |
| 2019-12-31 | 3.30% | NT$369.37 Million | NT$11.21 Billion | +2.80pp |
| 2018-12-31 | 0.49% | NT$53.48 Million | NT$10.85 Billion | +11.37pp |
| 2017-12-31 | -10.88% | NT$-1.15 Billion | NT$10.59 Billion | +1.00pp |
| 2016-12-31 | -11.88% | NT$-1.16 Billion | NT$9.78 Billion | -0.16pp |
| 2015-12-31 | -11.72% | NT$-1.16 Billion | NT$9.91 Billion | -12.64pp |
| 2012-12-31 | 0.92% | NT$61.51 Million | NT$6.68 Billion | +0.64pp |
| 2011-12-31 | 0.28% | NT$15.49 Million | NT$5.45 Billion | -0.20pp |
| 2010-12-31 | 0.49% | NT$18.97 Million | NT$3.88 Billion | -0.34pp |
| 2009-12-31 | 0.83% | NT$22.77 Million | NT$2.75 Billion | -- |